Functional role of the conserved proline in helix 6 of the human bradykinin B2 receptor

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 1001-1006

  Haffemayer, Benjamin ^a   Richard, Eric ^a   Mattras, Hélène ^a   Marie, Jacky ^a  

^a CENTRE DE BIOCHIMIE STRUCTURALE   (France)

Author keywords

Activation; Bradykinin; G protein coupled receptor (GPCR); Mutagenesis; Proline

Indexed keywords

ALANINE; BRADYKININ B2 RECEPTOR; GLYCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE; PROLINE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; MUTAGENESIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ASPARAGINE; BRADYKININ; CERCOPITHECUS AETHIOPS; CONSERVED SEQUENCE; COS CELLS; ENDOCYTOSIS; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PROLINE; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, BRADYKININ B2; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 37549037066     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.069     Document Type: Article

References (30)

1. Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 103 (2004) 21-80
2. Marie J., Richard E., Pruneau D., Paquet J.L., Siatka C., Larguier R., Ponce C., Vassault P., Groblewski T., Maigret B., and Bonnafous J.C. Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure. J. Biol. Chem. 276 (2001) 41100-41111
3. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrinol. Rev. 21 (2000) 90-113
4. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
5. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., Schertler G.F., Weis W.I., and Kobilka B.K. Crystal structure of the human beta(2) adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
6. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, T.S. Kobilka, H.J. Choi, P. Kuhn, W.I. Weis, B.K. Kobilka, R.C. Stevens, High-resolution crystal structure of an engineered human {beta}2-adrenergic G protein coupled receptor, Science (2007).
7. Sansom M.S., and Weinstein H. Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices. Trends Pharmacol. Sci. 21 (2000) 445-451
8. Ballesteros J.A., Shi L., and Javitch J.A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60 (2001) 1-19
9. McAllister S.D., Hurst D.P., Barnett-Norris J., Lynch D., Reggio P.H., and Abood M.E. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. J. Biol. Chem. 279 (2004) 48024-48037
10. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., and Javitch J.A. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by rotamer toggle switch. J. Biol. Chem. 277 (2002) 40989-40996
11. Marie J., Koch C., Pruneau D., Paquet J.L., Groblewski T., Larguier R., Lombard C., Deslauriers B., Maigret B., and Bonnafous J.C. Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI. Mol. Pharmacol. 55 (1999) 92-101
12. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
13. Jarnagin K., Bhakta S., Zuppan P., Yee C., Ho T., Phan T., Tahilramani R., Pease J.H., Miller A., and Freedman R. Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists. J. Biol. Chem. 271 (1996) 28277-28286
14. Bellucci F., Meini S., Cucchi P., Catalani C., Reichert W., Zappitelli S., Rotondaro L., Quartara L., Giolitti A., and Maggi C.A. A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis. Br. J. Pharmacol. 140 (2003) 500-506
15. Wigley W.C., Corboy M.J., Cutler T.D., Thibodeau P.H., Oldan J., Lee M.G., Rizo J., Hunt J.F., and Thomas P.J. A protein sequence that can encode native structure by disfavoring alternate conformations. Nat. Struct. Biol. 9 (2002) 381-388
16. Pan Y., Wilson P., and Gitschier J. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J. Biol. Chem. 269 (1994) 31933-31937
17. Kolakowski Jr. L.F., Lu B., Gerard C., and Gerard N.P. Probing the "message:address" sites for chemoattractant binding to the C5a. J. Biol. Chem. 270 (1995) 18077-18082
18. Stitham J., Martin K.A., and Hwa J. The critical role of transmembrane prolines in human prostacyclin receptor activation. Mol. Pharmacol. 61 (2002) 1202-1210
19. Konopka J.B., Margarit S.M., and Dube P. Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. Proc. Natl. Acad. Sci. USA 93 (1996) 6764-6769
20. Ladds G., Davis K., Das A., and Davey J. A constitutively active GPCR retains its G protein specificity and the ability to form dimers. Mol. Microbiol. 55 (2005) 482-497
21. Sansom M.S., and Weinstein H. Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices. Trends Pharmacol. Sci. 21 (2000) 445-451
22. Chou P.Y., and Fasman G.D. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47 (1978) 251-276
23. Gether U., Ballesteros J.A., Seifert R., Sanders-Bush E., Weinstein H., and Kobilka B.K. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J. Biol. Chem. 272 (1997) 2587-2590
24. Kenakin T. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol. Sci. 24 (2003) 346-354
25. Aramori I., Zenkoh J., Morikawa N., O'Donnell N., Asano M., Nakamura K., Iwami M., Kojo H., and Notsu Y. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol. 51 (1997) 171-176
26. Pruneau D., Chorny I., Benkovitz V., Artru A., Roitblat L., and Shapira Y. Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma. J. Neurotrauma 16 (1999) 1057-1065
27. Buck E., and Wells J.A. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. Proc. Natl. Acad. Sci. USA 102 (2005) 2719-2724
28. Aramori I., Zenkoh J., Morikawa N., Asano M., Hatori C., Sawai H., Kayakiri H., Satoh S., Inoue T., Abe Y., Sawada Y., Mizutani T., Inamura N., Nakahara K., Kojo H., Oku T., and Notsu Y. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. Mol. Pharmacol. 52 (1997) 16-20
29. Meini S., Cucchi P., Bellucci F., Catalani C., Faiella A., Rotondaro L., Quartara L., Giolitti A., and Maggi C.A. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists. Biochem. Pharmacol. 67 (2004) 601-609
30. Ballesteros J.A., and Weinstein H. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. Biophys. J. 62 (1992) 107-109